No headlines found.
No press releases found.
No news found.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Universe Pharmaceuticals - trades on the NASDAQ stock market under the symbol UPC.
As of December 12, 2025, UPC stock price declined to $3.98 with 11,678 million shares trading.
UPC has a beta of 2.04, meaning it tends to be more sensitive to market movements. UPC has a correlation of 0.05 to the broad based SPY ETF.
UPC has a market cap of $60.60 million. This is considered a Micro Cap stock.
In the last 3 years, UPC traded as high as $7,488.00 and as low as $2.51.
UPC has underperformed the market in the last year with a return of -87.7%, while the SPY ETF gained +14.0%. In the last 3 month period, UPC fell short of the market, returning -0.7%, while SPY returned +4.0%. However, in the most recent 2 weeks UPC has outperformed the stock market by returning +1.0%, while SPY returned -0.2%.
UPC support price is $3.87 and resistance is $4.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that UPC shares will trade within this expected range on the day.
